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Abstract: Glioblastoma (GBM) is a deadly brain tumor, with fast recurrence even after surgical
intervention, radio- and chemotherapies. One of the reasons for relapse is the early invasion of
surrounding brain parenchyma by GBM, rendering tumor eradication difficult. Recent studies
demonstrate that, in addition to eliminate possible residual tumoral cells after surgery, radiation
stimulates the infiltrative behavior of GBM cells. The intermediate conductance of Ca2+-activated
potassium channels (KCa3.1) play an important role in regulating the migration of GBM. Here,
we show that high dose radiation of patient-derived GBM cells increases their invasion, and induces
the transcription of key genes related to these functions, including the IL-4/IL-4R pair. In addition,
we demonstrate that radiation increases the expression of KCa3.1 channels, and that their
pharmacological inhibition counteracts the pro-invasive phenotype induced by radiation in tumor
cells. Our data describe a possible approach to treat tumor resistance that follows radiation therapy
in GBM patients.
Keywords: Glioblastoma; KCa3.1; radiation; invasion; IL-4
1. Introduction
Glioblastoma (GBM) is the most common and deadly primary brain tumor in adults [1]. Despite
the current standard multimodal treatment regimen, including surgery, and/or adjuvant chemo- and
radiotherapy (RT), mean survival in GBM patients remains low (less than 15 months) [2,3]. This poor
patient prognosis results from the high proliferation rate of GBM cells, and from the ability of these
cells to spread into surrounding brain parenchyma, thus escaping surgical resection, with rapid
appearance of new tumor masses. It has been shown that 80% of tumor recurrence occurs at the
resection margins, where the highest radiation doses are delivered [4]. However, invading GBM cells
intrinsically show decreased susceptibility to apoptosis, making radiotherapy and chemotherapy,
as well as radiation surgery, poorly effective [5,6]. For all these reasons, new strategies to suppress
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GBM cell migration are urgently needed. Recent studies demonstrated that radiation induces GBM
cell migration, acting both on tumor cells, increasing invasiveness index, and on normal brain
parenchyma, increasing chemokine secretion (such as CXCL12) from stromal cells [7–9]. Autocrine
and paracrine CXCL12 is a signal which determines the specific invasion pattern of GBM cells in
the brain, the so-called Sherer’s structures [10]. However, cell invasion also requires the activity of
various calcium and volume-sensitive ion channels located at the front and the rear edges of migrating
cells [11]. Among the ion channels activated during GBM cell migration, growing attention is given
to potassium channels, in particular those belonging to the family of calcium-activated potassium
channels [12,13]. Previous studies demonstrated that the inhibition of the intermediate-conductance
calcium activated potassium channel KCa3.1 blocked CXCL12-induced migration in human primary
GBM cells [14,15]. Our current study shows that treatment with a single high radiation, even higher
than that administered in radiosurgery for recurrent GBM [16], increases the migration and invasion
of the human GL-15 cell line and of some primary patient-derived human GBM cells. Radiation
also induces the transcription of key genes related to migration and invasion, such as CXCL12
and CXCR4, metalloproteinases, and some transcription factors. In addition, we describe that
radiation induces the functional over-expression of KCa3.1 channels, and that the inhibition of
these channels with 1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34) counteracts the
expression of the pro-invasive genes induced by radiation in tumor cells. Among the genes analyzed,
we measured the level of interleukin-4 (IL-4), a T helper type 2 (TH2) cytokine, and its receptor
(IL-4R). IL-4 suppresses the cancer-directed immune surveillance of myeloid cells and increases tumor
metastasis in carcinoma [17]. We described, for the first time, that high radiation treatment increases
IL-4 and IL-4R mRNA as well as IL-4 protein in irradiated GBM cells. Considering that AP-1 controls
the transcription of the KCa3.1 gene KCNN4 [18] and that IL-4/IL-4R signaling regulates KCa3.1
expression through the activation of the AP-1 transcription factor [19], this signaling could be relevant
upon GBM radiation. Our results suggest a possible new approach to counteract radiation-induced
GBM migration that follows radiosurgery in patients with recurrent GBM. Co-treatment with a KCa3.1
inhibitor and the currently approved drugs (e.g., Temozolomide) during the radiation protocol could
decrease the induction of pro-invasive genes. Of note, the selective KCa3.1 inhibitor used in this work
(TRAM-34) has a structural analogue drug, Senicapoc®, which has been already used in clinical trials
for sickle cell anemia and has been shown safe for patients [20].
2. Results
2.1. The Functional Expression of KCa3.1 Channels Increases in Irradiated Glioblastoma (GBM) Cells
We exposed a human GBM cell line (GL-15) and primary GBM cells derived from patients
(GBM18, GBM19, and GBM45) to a single high radiation dose, higher than that usually administered
to patients with recurrent GBM, in stereo radio-surgery [16]. For this reason, we first verified the
survival of GL-15 cells, 72 h after irradiation protocol, by MTT assay. As shown in Supplementary
Figure S1, the viability of irradiated GL-15 cells was similar to controls. To investigate the effect
of radiation on KCa3.1 channel expression, human GBM cells were irradiated and analyzed by the
qRT-PCR for KCNN4 expression, after 72 h. As shown in Figure 1A, upon radiation, GL15 cells
increased the expression of the KCNN4 gene approximately two-fold. Similar results were obtained in
primary GBM cells, where radiation increased the KCNN4 level in each cell population, compared to
their control (Figure 1B). We also evaluated the functional activity of KCa3.1 channels in GBM cells,
by electrophysiological recordings, 48–72 h after irradiation. Figure 1C shows representative KCa3.1
current traces obtained in control or irradiated GL-15 cells. As shown in Figure 1D, and, in line with
the mRNA expression, an increased potassium current with the pharmacological properties of KCa3.1
was observed in irradiated GL-15 cells.
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Figure 1. (A,B) Expression analysis by qRT-PCR of KCNN4 mRNA in GL-15 cells (A), in 
patient-derived primary glioblastomas (GBMs) (GBM18, GBM19, and GBM45) (B) after 1 cycle of 
radiation (35 Gy). (A) * p < 0.05 vs. control (C) GL-15; (B) * p < 0.05 vs. respective controls (C), n = 3 (in 
duplicate); (C) Current traces obtained from control (C) and irradiated GL-15 cells applying 1 s long 
voltage ramps from −90 to +20 mV, from a holding potential of −60 mV. Data are shown as 
current–voltage relationships, by plotting the current amplitude as a function of the applied voltage. 
Black and red traces are in the presence of external SKA-31 (3 µM), and external SKA-31 (3 µM) + 
1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM)-34 (3 µM), respectively. (D) Mean 
KCa3.1 current density (current amplitude to electrical capacitance ratio) assessed at 0 mV as the 
TRAM-34 sensitive current. N = 11 cells for C and n = 16 cells for irradiated, * p < 0.05 vs. C. 
2.2. KCa3.1 Inhibition Decreases Radiation-Induced Cell Migration and Invasion 
We have previously shown that GBM cell migration and invasion, both in in vitro and in vivo 
experimental systems, can be induced and sustained by KCa3.1 activity [14,21]. To investigate 
whether the increased expression of KCa3.1 channels in irradiated GBM was associated with 
enhanced migration and invasion capabilities, these activities were tested in GL-15 cells in the 
presence of the KCa3.1 inhibitor, TRAM-34 (5 µM), 24 h after irradiation. As shown in Figures 2A 
and B, radiation induced an increase of basal migration and invasion through a layer of extracellular 
matrix (Matrigel). The inhibition of channel function significantly reduced the effects of radiation 
(Figure 2B). Invasion assay was also performed on human GBM18, GBM19, and GBM45 cells and, 
similarly, the increase of cell invasion induced by radiation was abolished by TRAM-34 (Figure 2C). 
Figure 1. (A,B) Expression analysis by qRT-PCR of KCNN4 mRNA in GL-15 cells (A), in patient-derived
primary glioblastomas (GBMs) (GBM18, GBM19, and GBM45) (B) after 1 cycle of radiation (35 Gy).
(A) * p < 0.05 vs. control (C) GL-15; (B) * p < 0.05 vs. respective controls (C), n = 3 (in
duplicate); (C) Current traces obtained from control (C) and irradiated GL-15 cells applying 1 s
long voltage ramps from −90 to +20 mV, from a holding potential of −60 mV. Data are shown as
current–voltage relationships, by plotting the current amplitude as a function of the applied voltage.
Black and red traces are in the presence of external SKA-31 (3 µ ), and external SKA-31 (3 µ ) +
1-[(2-Chlorophenyl)diphenyl ethyl]-1H-pyrazole (TRAM)-34 (3 µM), respectively. (D) Mean KCa3.1
current density (current amplitude to electrical capacitance ratio) assessed at 0 mV as the TRAM-34
sensitive current. N = 11 cells for C and n = 16 cells for irradiated, * p < 0.05 vs. C.
2.2. a3.1 Inhibition ecreases adiation-Induced ell igration and Invasion
e a e re io sly s o t at cell igratio a i asion, both in in vitro a i vivo
ex eri e tal systems, can be induced and sustained by KCa3.1 activity [14,21]. To investigate whether
the increased expression of KCa3.1 channels in irradiated GBM was associated with enhanced
migration and invasio capabilities, these activities were tested in GL-15 cells in the presence of
the KCa3.1 inhibitor, TRAM-34 (5 µM), 24 h after irradiation. As show in Figure 2A,B, radiation
i uced an increase of basal migration and invasion through a layer of extracellular matrix (Matrigel).
The inhibition of channel function significantly reduced the effects of radiation (Figure 2B). Invasi
assay was also performed on human GBM18, GBM19, and GBM45 cells and, similarly, the increase of
cell invasion induced by radiation was abolished by TRAM-34 (Figure 2C).
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Figure 2. (A,B) Migration and invasion assays of irradiated GL-15 cells (after 24 h), in the presence or 
absence of 5 µM of TRAM-34. * p < 0.05 vs. control (C) GL-15. # p < 0.05 vs. irradiated GL-15 n = 3 (in 
duplicate); (C) Cell invasion assay of irradiated human primary GBMs (GBM18, GBM19, and 
GBM45) (after 24 h) in the presence or absence of TRAM-34 (5 µM for 24 h), * p < 0.05 vs. control 
GBMs (C). # p < 0.05 vs. irradiated GBMs. n = 3 (in duplicate). 
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In order to reveal the mechanisms behind the increased invasive ability of irradiated GBM cells, 
we investigated the effects of irradiation on the mRNA expression of some key genes involved in cell 
invasion. We found that radiation induced the up-regulation of the chemokine CXCL12 and its 
receptor CXCR4, of the metalloproteinases 9 and 12 (MMP9 and MMP12), and of key transcription 
factors involved in the expression of genes related to migration of cancer cells. Among them, AP-1 
(activating protein 1), ATF2 (activating transcription factor 2), EGR3 (early growth response 3), and 
REST (RE-1 Silencing transcription factor) (Figure 3A,B). In order to understand if KCa3.1 channel 
activity could contribute to the gene expression profile induced by radiation in GL-15 cells, cells 
were treated with TRAM-34 (48 h, 5 µM) and analyzed by qRT-PCR. Data shown in Figure 3A and B 
demonstrated that inhibition of KCa3.1 activity reduced the expression of genes induced by 
radiation. We also found that the expression of KCNN4 (Figure 3A) and the corresponding KCa3.1 
current was modulated by channel activity (Supplementary Figure S2). As shown in Figure 3C, 
similar results were obtained in primary GBM cells derived from patients, where radiation 
up-regulated 8 out of 9 tested genes, partially reduced by TRAM-34 treatment. The effects of 
radiation on gene expression in each cell population is shown in Supplementary Table S1. These data 
are in accordance with the increased ability of GBM cells to invade the extracellular matrix shown 
before, and describe an important effect of radiation as modulator of gene expression, increasing the 
tumor cell invasiveness. 
Figure 2. (A,B) Migration and invasion assays of irradiated GL-15 cells (after 24 h), in the presence or
absence of 5 µM of TRAM-34. * p < 0.05 vs. control (C) GL-15. # p < 0.05 vs. irradiated GL-15 n = 3 (in
duplicate); (C) Cell invasion assay of irradiated human primary GBMs (GBM18, GBM19, and GBM45)
(after 24 h) in the presence or absence of TRAM-34 (5 µM for 24 h), * p < 0.05 vs. control GBMs (C).
# p < 0.05 vs. irradiated GBMs. n = 3 (in duplicate).
. . . ti it I I l i i ti -I i ti of Genes Related to GBM Cell Invasion
I t l t i i t i r i i ilit f irra iate cells,
i ti t t ff t f i i ti t i f i l i ll
i i . e found that radiation i duced the up-regulation of the chemokine CXCL12 and its receptor
CXCR4, of the metalloproteinases 9 and 12 (MMP9 and MMP12), and of key transcription fact rs
inv lved in th expression of genes related to migrati n of c ncer cells. Among them, AP-1 (activating
protein 1), ATF2 (activating transcription factor 2), EGR3 (early growth response 3), and REST (RE-1
Silencing transcription f cto ) (Figure 3A,B). In order to understand if KCa3.1 channel activity could
contribute to the gene expression profile induced by radiation in GL-15 cells, cells were treated with
TRAM-34 (48 h, 5 µM) and analyzed by qRT-PCR. Data shown in Figure 3A,B demonstrated that
inhibition of KCa3.1 activity reduced the expression of g nes induced by radiation. We also found
that the expr ssion f KCNN4 (Figure 3A) a d the corresponding KC 3.1 current was modulated by
han el activity (Supplementary Figure S2). As shown in Figure 3C, similar results were obtained
in primary GBM cells derived from patients, where radiation up-regulated 8 out of 9 t sted genes,
partially r uced by TRAM-34 treatment. The eff cts of radiation on gene expression in each cell
population is shown in Supplementary Table S1. These data are in accord nce with the increased
bil ty of GBM lls to invade the extr ce lular matrix shown before, and describe an important effect
of radiation as modulator of gene xpression, increasing the tumor cell i vasiveness.
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Figure 3. (A,B) Expression analysis by qRT-PCR of invasion-related genes in irradiated or control, 
(C) GL-15 cells upon TRAM-34 treatment (5 µM, 48 h); * p < 0.05 vs. control GL-15. # p < 0.05 vs. 
irradiated GL-15 n = 3 (in duplicate). (C) Same as in A and B for human primary GBM cells, upon 
TRAM-34 treatment (5 µM, 48 h); * p < 0.05 vs. GBMs. # p < 0.05 vs. irradiated GBMs n = 3 (in 
duplicate). 
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and 2.5-fold (2.7 ± 0.1), respectively. KCa3.1 inhibition with TRAM-34 decreased protein expression 
in both cell cultures (GL-15: 1.3 ± 0.1; GBM18: 2.1 ± 0.2). Intracellular IL-4 was measured in the 
presence of Brefeldin A (10 µg/mL), which blocks protein transport from the endoplasmic reticulum. 
Figure 3. (A,B) Expression analysis by qRT-PCR of invasion-related genes in irradiated or control,
(C) GL-15 cells upon TRAM-34 treatment (5 µM, 48 h); * p < 0.05 vs. control GL-15. # p < 0.05 vs.
irradiated GL-15 n = 3 (in duplicate). (C) Same as in A and B for human primary GBM cells, upon
TRAM-34 treatment (5 µM, 48 h); * p < 0.05 vs. GBMs. # p < 0.05 vs. irradiated GBMs n = 3 (in duplicate).
2.4. Radiation-Induced IL-4/IL-4R Expression is Dependent on KCa3.1 Channel Activity
KCNN4 transcription involves the IL-4/IL-4R axis in cultured rat and mouse microglia cells [18,22],
and IL-4R and KCNN4 expression in GBM negatively correlates with patient survival, as shown in
the TCGA database (Supplementary Figure S3). In order to determine the effect of radiation on
IL-4/IL-4R in GBM cells, we studied their expression in GL-15 cells and in human primary GBM cells.
As shown in Figure 4A, IL-4 and IL-4R transcription significantly increased upon irradiation in GL-15
cells, compared to controls. Inhibition of KCa3.1 channel function reduced cytokine transcription,
suggesting that radiation-induced expression is sustained by channel activity. Irradiated human
primary GBM cells also increased IL-4 and IL-4R gene expression; however, KCa3.1 inhibition with
TRAM-34 (48 h after radiation) only reduced cytokine expression (Figure 4B). We also measured the
protein level of IL-4 in GL-15 and in human GBM cells by cytofluorimetry. As shown in Figure 4C,
in line with the mRNA expression experiments, radiation increased the level of intracellular IL-4 in
GL-15 and GBM18 cells approximately 2-fold (1.89 ± 0.04) and 2.5-fold (2.7 ± 0.1), respectively. KCa3.1
inhibition with TRAM-34 decreased protein expression in both cell cultures (GL-15: 1.3 ± 0.1; GBM18:
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2.1 ± 0.2). Intracellular IL-4 was measured in the presence of Brefeldin A (10 µg/mL), which blocks
protein transport from the endoplasmic reticulum.
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GBM19, GBM45, and GBM137) * p < 0.05 vs. C; # p < 0.05 vs. irradiated GBM n = 4 (in duplicate). (C) 
IL-4 production by GL-15 and GBM18 cells, evaluated by intracellular immunostaining and flow 
cytometry analysis. Histograms are representative of two independent experiments. Isotype staining 
was performed on both control and irradiated cells. Gray line marks control histogram peak. The 
values shown represent the median fluorescence intensity (MFI) of each histogram/sample. 
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reduces GBM invasion in vitro and in mouse models, affecting both glioma cells and microglia 
[14,21]. We now wanted to verify the hypothesis that KCa3.1 could also be involved in modulating 
radiation-induced GBM cell invasiveness. In particular, we focused on the effect of radiation doses 
higher than those used in stereo radio-surgery for recurrent GBM [16]. We demonstrated that this 
treatment increased the invasive ability of GL-15, a human GBM cell line, and of primary GBM cells 
derived from patients. GL-15 cells were chosen in this study for their high invasiveness [14,21,24]. 
Many different reports demonstrated that different radiation protocols stimulated cell migration in 
different cancers (see [25] for a review) as well as in GBM [26–29]. However, the mechanisms 
underlying the induction of a pro-invasive phenotype are still under investigation. Here, we show 
that cell irradiation with a unique high dose induces gene expression and the functional 
up-regulation of KCa3.1 channels, as demonstrated by qRT-PCR and electrophysiological recordings 
in GL-15 cells and in primary GBM cells derived from patients. Recently, in human T98G and 
U87MG cell lines, fractioned radiation has been shown to up-regulate KCa3.1 channels. In particular, 
it was reported that the blockade of KCa3.1 radiosensitized these highly proliferative cell lines, 
Figure 4. (A) Expression analysis by qRT-PCR of IL-4 and IL-4R in irradiated or untreated (C) GL-15
cells after TR -34 treat ent (5 µ , 48 h). * p < 0.05 vs. control GL-15. # p < 0.05 vs. irradiated
GL-15 n = 3 (in duplicate). (B) Expression analysis, by qRT-PCR, of IL-4 and IL-4R in B s (GBM18,
GBM19, GBM45, and GB 137) * p < 0.05 vs. C; # p < 0.05 vs. irradiated GBM n = 4 (in duplicate).
(C) IL-4 production by GL-15 and GBM18 cells, evaluated by intracellular immunostaining and flow
cytometry analysis. Histograms are representative of two independent experiments. Isotype staining
was performed on both control and irradiated cells. Gray line marks control histogram peak. The values
shown represent the median fluorescence intensity (MFI) of each histogram/sample.
3. Discussion
GBM is an invasive brain tumor, able to reach and colonize brain regions far from the original
tumoral core. The poor prognosis of GBM patients is primarily associated with the invasive phenotype
and the growth rate of GBM cells [23]. We have previously shown that KCa3.1 inhibition reduces
GBM invasion in vitro and in mouse models, affecting both glioma cells and microglia [14,21]. We now
wanted to verify the hypothesis that KCa3.1 could also be involved in modulating radiation-induced
GBM cell invasiveness. In particular, we focused on the effect of radiation doses higher than those
used in stereo radio-surgery for recurrent GBM [16]. We demonstrated that this treatment increased
the invasive ability of GL-15, a human GBM cell line, and of primary GBM cells derived from patients.
GL-15 cells were chosen in this study for their high invasiveness [14,21,24]. Many different reports
demonstrated that different radiation protocols stimulated cell migration in different cancers (see [25]
for a review) as well as in GBM [26–29]. However, the mechanisms underlying the induction of
a pro-invasive phenotype are still under investigation. Here, we show that cell irradiation with
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a unique high dose induces gene expression and the functional up-regulation of KCa3.1 channels,
as demonstrated by qRT-PCR and electrophysiological recordings in GL-15 cells and in primary
GBM cells derived from patients. Recently, in human T98G and U87MG cell lines, fractioned
radiation has been shown to up-regulate KCa3.1 channels. In particular, it was reported that the
blockade of KCa3.1 radiosensitized these highly proliferative cell lines, impairing their clonogenic
properties in vitro and their ectopic growth in vivo [30]. Another calcium-dependent potassium
channel, KCa1.1, is up-regulated upon radiation, and its increased activity was associated with the
increased invasive behavior of U87MG cells [12]. Here we show that very high doses of radiation
also affects GBM cell migration. In all the tested GBM cells, we found an increased ability to
invade a Matrigel layer. We also demonstrated that this gained function was related to an increased
functional KCa3.1 expression, because channel inhibition with TRAM-34 significantly reduced the
radiation-induced cell invasion. Recently, we have shown that KCa3.1 channel function is involved
in the activation state of microglial cells and modulates the transcription of inflammatory genes [22].
In the present study, we started from the observation that radiation increased KCa3.1 function,
and evaluated the expression of key genes related to cell invasion and/or reported to be increased after
radiation in GBM, such as CXCL12 [12,31], CXCR4 [32], EGFR [33,34], and metalloproteinases [35,36].
Our data demonstrate that the altered gene expression profile induced by radiation was sustained
by KCa3.1 activity, and was modulated by TRAM-34 treatment of GL-15 cells. In primary GBM
cells, radiation boosted gene transcription of several genes among those analyzed, and some key
genes were also modulated by KCa3.1 inhibition. We also investigated whether transcription
factors involved in the expression of invasion-related genes could be modulated by radiation. Here,
we report the increased expression of AP-1, ATF2, REST, and EGR3, all transcription factors involved
in cancer cell invasive behavior [36–40]. AP-1 together with ATF2, EGR3, and REST, have top
transcription factor-binding sites in the KCNN4 gene promoter, as evaluated in the QIAGEN database
(https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNN4). The AP-1 dependent transcription
of KCa3.1 channels was previously shown in T cells and microglia [17,18]. In contrast, in vascular
smooth muscle cells, REST activity suppresses KCNN4 expression, with effects on cell proliferation [41]
likely reflecting cell-specific responses. To our knowledge, this is the first report of EGR3 expression
in GBM. We suggest that these results could explain the mechanisms underlying the increased
invasive capabilities induced in GBM by very high doses of radiation, such as those occurring
upon radiation surgery. One of the pathways involved in KCNN4 transcription is the signaling
through the IL-4/IL-4R pair, together with the activation of AP-1 factor [17,18]. Radiation induces
the expression of the IL-4 gene in human carcinoma cells [42]. In our experiments, we report the
increase of IL-4 and IL-4R expression in irradiated GL-15 cells. This is different from other reports on
medulloblastoma and GBM cells exposed to a single dose (5 Gy) of gamma radiation, where IL-4R
decreased [43]. Furthermore, it must be considered that IL-4, a classical type 2 cytokine, may induce
type 1 immunity, increasing survival of glioma-bearing mice and decreasing tumorigenicity of
sarcoma cell in vivo [44,45]. Nevertheless, IL-4 also modulates the brain microenvironment in glioma,
with effects on tumor activated myeloid cells, and the promotion of tumor growth and invasiveness
(reviewed in [46,47]). It has been reported that GBM patients have higher central and peripheral
expression of IL-4 [48], and we here describe that the inhibition of the KCa3.1 channel reduces IL-4
transcription in GL-15 cells, suggesting that radiation-induced expression is sustained by channel
activity. Irradiated primary GBM cells showed a similar behavior in terms of IL-4 and IL-4R expression
while KCa3.1 inhibition only affects cytokine expression. FACS analysis also supported the increase
of intracellular IL-4 in irradiated GL-15 and GBM18 cells, and the key modulatory role of KCa3.1
activity. This finding may have significant implications for future therapeutic approaches, since IL-4
has immune suppressive functions in the GBM microenvironment, acting as inducer of a pro-tumor,
anti-inflammatory microglia phenotype [22,47]. To our knowledge, this is the first study describing
that GBM cells increase IL-4 expression upon treatment with a high dose of radiation.
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To summarize, we propose the following interpretation of our results: in GBM cells, a high
dose of radiation induces IL-4 and KCa3.1 expression, with the consequent intracellular calcium
mobilization [40] and gene transcription of pro-invasive factors. The small sample size of patient
tissues and the high heterogeneity of GBM tumor requires further analyses to obtain conclusive
translational data. However, the understanding of these mechanisms of action could have important
applications to reduce GBM cell invasiveness in patients, also with the possibility to repurpose
Senicapoc®, a compound that is structurally similar to TRAM-34 [19] and has been previously tested
in clinical trials for other diseases.
4. Materials and Methods
4.1. Materials
All cell culture reagents D-MEM (high-Glucose), fetal bovine serum (FBS), amphotericin B,
penicillin G, streptomycin, and glutamine were from Invitrogen (Carlsbad, CA, USA). All salts and
solvents were form Sigma-Aldrich (Saint Louis, MO, USA).
4.2. Cell Line Culture and Radiation Protocol
Radiation was performed on sub-confluent GL-15, cultured as previously described [14],
and primary GBM cells in T25 flasks in complete growth medium. Cells were exposed to X-ray
in a Raycell cabinet system (Ottawa, ON, Canada) calibrated for blood bags with a dose of 35 Gray
(Gy) (1 cycle).
4.3. Primary Human GBM Cells
Tumor specimens were obtained from the Neurological Science Department of Sapienza Medical
School and from Neuromed, from primary GBM in adult patients who gave informed consent to
the research proposals (Supplementary Table S2). The study was conducted in accordance with the
Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Policlinico Umberto
I and Neuromed. Ethic code: 23 April 2015, Rif.3623 Prot.2061/15, Ethics Committee of Policlinico
Umberto I; 31 July 2012, Prot. 7/12, Ethics Committee of Neuromed. Tissues were processed within
half an hour from surgical resection. Histopathological typing and tumor grading were done according
to the WHO criteria, resulting as grade IV. In detail, tumor tissues were mechanically dissociated
to cell suspensions and centrifuged at 800× g for 5 min. Red blood cells were lysed with 4 vol of
ammonium chloride buffer (in mM: 154 NH4Cl, 10 K2CO3, and 0.1 EDTA) at 4 ◦C for 5 min. Tumor cells
were resuspended in serum-free growth medium (D-MEM with 100 IU/mL penicillin G, 100 mg/mL
streptomycin, 4 mM glutamine, and 1 mM sodium pyruvate) and cultured at 37 ◦C in a humidified
atmosphere with 5% CO2. Twenty-four hours later, non-adherent cells were removed, and the growth
medium was supplemented with 10% heat-inactivated FBS, with changes every 48 h. After about
10 days, cells were sub-cultured. In this work we used four primary cultures: GBM18, GBM19, GBM45,
and GBM137. These primary cell cultures were chosen because they responded to chemokines in
chemotaxis assays and expressed KCa3.1 channels [15,49,50].
4.4. Migration and Invasion Assays
Twenty-for hours after irradiation, irradiated or control sub-confluent cells were trypsinized,
and plated in invasion medium (DMEM supplemented with 100 IU/mL penicillin G and 100 µg/mL
streptomycin, 0.1% BSA and 25 mM HEPES, pH 7.4), at a density of 7 × 103 cells/cm2 on poly-lysine
or Matrigel-coated transwells (Corning, 8 µm pore size, Corning, NY, USA). Cells were incubated at
37 ◦C for 4 h (migration) or for 24 h (invasion) with 2 mM hydroxyurea added to both chambers to
prevent cell proliferation, then fixed in ice-cold 10% trichloroacetic acid for 10 min in the presence or
absence of 5 µM of TRAM-34. Cells adhering to the upper side of the filter were scraped off, whereas
cells invaded through the insert were stained with a solution containing 50% isopropanol, 1% formic
Cancers 2019, 11, 279 9 of 14
acid, and 0.5% (w/v) Brilliant blue R 250 (Sigma-Aldrich) and counted on the entire membrane area
(at least 20 fields) with a 20× objective.
4.5. Electrophysiology
Twenty-for hours after irradiation, GBM cells were plated on petri dishes (2 × 104 cells/dish)
and tested after 24–48 h of TRAM-34 treatment (48–72 h after radiation). The whole-cell, patch-clamp
configuration was used for electrophysiological recordings. Currents were amplified with a HEKA
EPC-10 amplifier (List Medical, Darmstadt, Germany), digitized with a 12-bit A/D converter (TL-1,
DMA interface; Axon Instruments, Foster City, CA, USA), and analyzed with the Patch Master
package (version 2 × 60, Heka Elektronik, Holliston, MA, USA) and Microcal Origin 6.0 software.
For on-line data collection, macroscopic currents were filtered at 3 kHz and sampled at 50 µs/point.
The external solution contained (in mM): NaCl 140, KCl 5, CaCl2 2, MgCl2 2, MOPS 5, glucose 10,
(pH 7.4). The internal solution contained (in mM): KCl 150, EGTA-K 1, MgCl2 1, MOPS 5, Na2ATP
5 (pH 7.20). CaCl2 was added to the internal solution to have a free Ca2+ concentration of 1 µM as
assessed using the program Webmax (https://web.stanford.edu/~{}cpatton/webmaxcS.htm). Access
resistances ranging between 5 and 15 MΩ were achieved and actively compensated to 50%. Following
the establishment of the whole-cell configuration, cells were stimulated by applying 1 s voltage ramps
from −90 to 20 mV from a holding potential of −60 mV. In order to achieve complete exchange
of the cytoplasm solution, electrophysiological experiments began 3 min after the achievement of
the whole cell configuration. After this time, the current ramps were sufficiently stable over time.
The KCa3.1 channel agonist SKA-31 (3 µM, Sigma-Aldrich) or NS309 (10 µM, Sigma-Aldrich) was
applied to maximally activate the KCa3.1 current, and then 3 µM TRAM-34 was added, together with
the channel agonist, to estimate the maximal KCa3.1 current. The current density was assessed by
dividing the current recorded at 0 mV by the cell capacitance measured by the amplifier. Data were
presented as mean +/− standard error. The one-way ANOVA test was applied to assess significant
differences among the three experimental groups (Control, Irradiated, and Irradiated plus TRAM-34,
Supplementary Figure 1), and the Student’s t-test was applied to detect differences between groups.
In both cases, a p < 0.05 was considered to be significant.
4.6. RNA Preparation and Analysis
Total RNA was isolated from cell cultures (irradiated or not) treated for 48 h with TRAM-34 or
vehicle. Treatments started 24 h after irradiation. RNA was isolated using Trizol reagent (Ambion,
Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s instructions. The cDNA
was prepared using the iScript Reverse Transcription Supermix (Bio-Rad Laboratories, Hercules, CA,
USA); quantitative real time PCR was performed using the SsoFast Evagreen Supermix (Bio-Rad
Laboratories) according to the protocol for use in the Biorad I cycler System. For the quantification
analysis, the comparative threshold cycle (Ct) method was used. The Ct values of each gene were
normalized to the Ct value of GAPDH in the same RNA sample. The gene expression levels were
evaluated by fold changes using the equation 2-ddCt. The primers used are reported in Table 1.
Table 1. Primers used in RNA analysis.
AP-1 Forward: 5′-AGAGGAAGCGCATGAGGAAC-3′
Reverse: 5′-CACCTGTTCCCTGAGCATGT-3′
ATF2 Forward: 5′-GGCCAATTGTCCCTGTACCA-3′
Reverse: 5′-ACCATGGTGACTGGTCGAAC-3′
CXCL12 Forward: 5′-AGCCAACGTCAAGCATCTCA-3′
Reverse: 5′-GTGGGTCTAGCGGAAAGTCC-3′
CXCR4 Forward: 5′-CCCTCCTGCTGACTATTCCC-3′
Reverse: 5′-TAAGGCCAACCATGATGTG-3′
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Table 1. Cont.
EGR3 Forward: 5′-AGTTTGCTAAACCAACTGCC-3′
Reverse: 5′-TTGGTCAGACCGATGTCCAT-3′
GAPDH Forward: 5′-CCCCTTCATTGACCTCAACTAC-3′
Reverse: 5′-GATGACAAGCTTCCCGTTCTC-3′
IL-4 Forward: 5′-GACTCTGTGCACCGAGTTGA-3′
Reverse: 5′-TCAGGAATCGGATCAGCTGC-3′
IL-4R Forward: 5′-ATGAAGGTCTTGCAGGAGCC-3′
Reverse: 5′-ACGTCATCCATGAGCAGGTG-3′
KCNN4 Forward: 5′-GGCTGAAACACCGGAAGCTC-3′
Reverse: 5′-CAGCTCTGTCAGGGCATCCA-3′
MMP2 Forward: 5′-AGATCTTCTTCTTCAAGGACCGGTT-3′
Reverse: 5′-ACAGCCTTCTCCTCCTGTGG-3′
MMP9 Forward: 5′-AACTACGACCGGGACAAG-3′
Reverse: 5′-TCCGCGGCCCTCGCTGGTAC-3′
MMP12 Forward: 5′-AGGAATCGGGCCTAAAATTG-3′
Reverse: 5′-TGCTTTTCAGTGTTTTGGTGA-3′
REST Forward: 5′-GTTAGAACTCATACAGGAGAA-3′
Reverse: 5′-AACTGCACTGATCACATTTAA-3′
4.7. Flow Cytometry Analysis
For evaluation of IL-4 production, GBM cells were treated with TRAM-34 (5 µM for 48 h) 24 h after
irradiation, maintained in complete medium in the presence of Brefeldin A (10 µg/mL) for the last 4 h,
and then detached with trypsin/EDTA. Cells were labeled with the fixable viability dye eFluorTM 780
(Invitrogen) to exclude dead cells from the analysis and stained using the BD Cytofix/CytopermTM
fixation/permeabilization kit according to the manufacturer’s instructions. APC mouse anti-human
IL-4 Ab (clone 8D4-8) was from BD Pharmingen and staining was performed at 4 ◦C for 20 min;
the corresponding Ab isotype was used as negative control. Samples were analyzed using a flow
cytometer FACS-Canto II (BD Biosciences) and data were elaborated using FlowJo 9.3.2 software (BD
Biosciences, San Jose, CA, USA). Quantification of IL-4 expression was reported as the fold-increase of
median fluorescence intensity of each sample versus control minus isotype value.
4.8. Statistical Analyses
Data were expressed as the mean ± SEM. Statistical significance was assessed by Student’s t-test
or one-way ANOVA followed by Student–Newman–Keuls method of comparison. All statistical
analyses were done using Sigma Plot 11.0 software (https://systatsoftware.com).
5. Conclusions
Data reported in this manuscript demonstrate that GBM cells irradiated with a single high dose
of 35 Gy to mimic the condition of stereotaxic radio-surgery performed in patients, increased the
invasion ability, by increasing the transcription level of genes involved in invasion and other in
transcription regulation. We found that the activity of KCa3.1 channels, whose functional expression
increased in irradiated cells, modulates these effects. We also found that a high radiation dose
stimulates the transcription of IL-4 and IL-4 receptors in GBM cells, again counteracted by KCa3.1
inhibition. This result suggests that high radiation can promote a more aggressive tumor phenotype,
also because IL-4 acts as an immunosuppressant, regulating GBM microenvironment. These effects
can be modulated by the activity of KCa3.1.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6694/11/3/279/s1,
Figure S1: MTT assay on irradiated GL-15 cells, Figure S2: Radiation-induced KCa3.1 activity is repressed after
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TRAM-34 treatment, Figure S3: Survival analysis based on expression of the indicated genes, Table S1: The effects
of radiation (IRR) and radiation + TRAM-34 (IRR+TRAM-34) treatment on gene expression in each cell population,
Table S2: GBM patient details.
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